NEW YORK ( TheStreet) -- Eight new names are joining ETF Deathwatch for December, and nine products are coming off the list.
Six are leaving due to increased investor interest, and three ETFs are exiting because they are now dead, delisted, and liquidated. ETF Deathwatch now consists of 374 (274 ETFs and 100 ETNs) names from the 1,445 listed for trading.
Even though there is a risk these exchange-traded products (ETPs) could eventually close, liquidity risk is present today. For example, the iPath US Treasury 5-Year Yield Bull (DFVL) hasn't traded since Sept. 13. It is just one of eight Zombie products going the entire month of November with zero volume.
(MFSA) is quoted Friday with a bid price of $37.14 and an ask of $112.10 (a spread of $74.96). Even more troubling is the fact that there are only 100 shares available at each end of those extremes. The average product on ETF Deathwatch is more than 31 months old and has $6.3 million in assets. Sponsor patience varies widely, with some closing non-profitable products within their first year while others seem willing to subsidize products forever. There are currently 44 exchange-traded funds and exchanged-traded notes on the list that have been on the market for more than five years. The quantity of funds with less than $2 million in assets stands at 60. The complete list of 374 products on ETF Deathwatch for December 2012 can be found
AdvisorShares Global Echo ETF
AlphaClone Alternative Alpha ETF
Credit Suisse Merger Arbitrage Liquid 2x Monthly ETN
C-Tracks Citi Volatility Index Total Return ETN
Guggenheim S&P Equal Weight Financials
iShares MSCI Denmark Capped Investable Market
QuantShares U.S. Market Neutral Value
SPDR S&P 400 Mid Cap Value ETF
The ETPs removed from ETF Deathwatch due to improved health:
Direxion Daily Healthcare Bull 3x
ETRACS DJ-UBS Commodity 2-4-6 Blended Futures ETN
iPath Seasonal Natural Gas ETN
iShares Asia/Pacific Dividend 30
iShares MSCI China Small Cap Index Fund
ProShares Ultra MSCI Europe
QuantShares U.S. Market Neutral Anti-Momentum
QuantShares U.S. Market Neutral High Beta
QuantShares U.S. Market Neutral Quality